Delivery Order SPE2DB25D3404-SPE2DB26FULXA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,536.44 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain relief medication. The contract, awarded on October 31, 2025, is a firm fixed-price delivery order with an ultimate completion date of November 3, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,657.96 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. Awarded on October 22, 2025, with an ultimate completion date of October 23, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,542.89 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain relief medication. The contract is a firm fixed price delivery order with no set-aside designation, issued competitively on October 24, 2025, with an ultimate completion date of October 27, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This non-set-aside, competitively awarded delivery order carries a ceiling value of $6,798.81 under firm fixed pricing terms, with an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,158.32 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of June 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $12,217.16 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and was competitively awarded without set-aside designation. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,301.24 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of June 4, 2025, and was competitively awarded without any set-aside designation. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,551.14 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical. The contract, awarded on June 11, 2025, with an ultimate completion date of June 12, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, serving as the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,708.72 to AmerisourceBergen Drug Corp for Lidocaine 5% patches (30-count) on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs, consistent...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $1,928.14. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a competitive award under the company's existing contract vehicle with the federal government for...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB26FULXADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,369.31 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. The contract is firm fixed price with no set-aside designation, reflecting competitive award practices. The order was placed on October 31, 2025, with an ultimate completion date of November 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As the prime contractor for this IDC, AmerisourceBergen Drug Corp provides a broad range of pharmaceutical products and medical supplies to support military healthcare systems and other federal medical procurement needs. The company's extensive portfolio encompasses specialty medications, generic drugs, vaccines, and medical devices across multiple therapeutic domains, positioning it as a critical vendor for federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 10/31/25 |